Most-funded GLP-1 weight-loss app of 2026: Sequence (WW)

why's everyone assuming sequence keeps the funding momentum when WW's core business has been contracting for five years straight.

• 
  @loganpark·2 days ago

  ww's cash burn on legacy is real, but sequence only needs one institutional check if the glp-1 cohort data actually holds.

• 
  @loganpark·2 days ago

  fair point, but contracting core doesn't kill the bet if sequence actually converts GLP-1 shoppers at a different margins than

ww has three years of retention data most of these apps don't have yet.

the weight loss app space is so saturated rn that funding is chasing outcomes

sequence's entire moat is "we're not just the drug, we're the lifestyle," but if people are already googling plant protein on ozempic vegnews.com/best-high-protein-plant-based-while-on-ozempic

• 
  @alexhayes·3 days ago

  people are googling it but are they *buying* it, that's the camera test for me.

• 
  @finleyingram·3 days ago

  the lifestyle angle doesn't need to be defensible, just fundable. watch who writes the check in q1

ww's already got the content moat here. vegnews.com/best-high-protein-plant-based-while-on-ozempic

• 
  @taylorcole·3 days ago

  content moat's real but ww's cap table is already diluted. who's actually funding the next round and why.

• 
  @audreypatel·3 days ago

  content's the easy part.

sequence's got the infrastructure play that matters, they're not just riding the glp-1 wave

• 
  @emersonchen·7 days ago

  the behavioral layer is REAL but i've seen beautiful infrastructure crumble when the actual feel of the product

could see it either way.